Drug Patent Watch

NOVEMBER 8, 2020

This chart shows the generic pharmaceutical companies that had the most successful drug patent challenges from 2015 to 2020. Companies that successfully challenge patents on branded drugs are granted six…. The post Most prolific drug patent challengers appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 40

Pharmaceutical Companies Drugs Pharmaceuticals 40

Alta Sciences

DECEMBER 13, 2024

His knowledge of pharmaceutical manufacturing and proven experience with GMP practices led him to quickly grow within the company, rising to Manufacturing Manager in 2015 before assuming his current role as Director of Manufacturing in 2022. Get to know Scott further with this Q&A: What inspired you to Join the CDMO Industry?

Science 52

Science Pharmaceuticals Production Drugs 52

The Pharma Data

JULY 28, 2021

Additionally, Viviane Monges will join EUROAPI, a future leading European company dedicated to the development, production, and marketing of active pharmaceutical ingredients (API), as an independent non-executive Chair of the Supervisory Board. At Wyeth Pharmaceuticals/Pfizer she served as CFO of the Global Pharma Business unit.

Pharmaceutical Companies 52

Pharmaceutical Companies International Pharmaceuticals Compliance 52

The Pharma Data

OCTOBER 21, 2020

Under an exclusive licensing agreement with Endo International’s (NASDAQ: ENDP) subsidiary, Endo Ventures Limited, Par Pharmaceuticals’ Sterile Products division will launch and distribute the product. Food and Drug Administration (FDA) to market Ephedrine Sulfate Injection in a ready-to-use 50mg/10 ml single use vial presentation.

FDA Approval 40

FDA Approval FDA Pharmaceutical Companies Pharmaceuticals 40

Drug Target Review

AUGUST 9, 2024

Drug formulation is the process of designing and producing a final medicinal product from an active pharmaceutical ingredient (API). Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems (9th ed.). Pharmaceutics. 2015 Sep;26 Suppl 5:v139-51. Epub 2015 Jul 4. What is drug formulation? G., & Ansel, H.

Science 59

Science Drugs Compliance Drug Development 59

The Pharma Data

JUNE 17, 2022

“By committing to bring biosimilar formulations such as Hyrimoz citrate-free HCF to patients, we are serving a critical need in expanding access to important medicines and fueling pharmaceutical innovation.”. 2,3 In 2015, the EMA and US FDA approved Humira ® HCF, which contains adalimumab at a concentration of 100 mg/mL.

Biosimilars 52

Biosimilars Pharmacokinetics FDA Approval Packaging 52

Drug Target Review

JUNE 12, 2023

Beginning in 2015, he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for the generation of novel molecular structures with the desired properties and generation of synthetic biological and patient data.

Metabolic Stability 92

Metabolic Stability Clinical Trials Small Molecule Pharmacokinetics 92

New Drug Approvals

JANUARY 31, 2024

The prevalence of non-alcoholic steatohepatitis (NASH), a form of NAFLD that is associated with hepatic inflammation and ballooning of hepatocytes, is expected to increase by 63% between 2015 and 2030 in the United States (Estes, Hepatology, 2018; 67(1): 123-133), where NASH is expected to become the leading cause of liver transplantation by 2020.

Treatment 52

Treatment Disease Pharmaceuticals Drugs 52

New Drug Approvals

SEPTEMBER 13, 2024

4] [6] Aticaprant was originally developed by Eli Lilly , was under development by Cerecor for a time, and is now under development by Janssen Pharmaceuticals. [2] 18] In February 2015, Cerecor Inc. 21] In August 2017, it was announced that Cerecor had sold its rights to aticaprant to Janssen Pharmaceuticals. [22] nM vs. 24.0

Treatment 62

Treatment Clinical Trials Pharmacokinetics Pharmaceuticals 62

The Pharma Data

JANUARY 6, 2021

Founded in 2015, Standigm has raised $23M from leading investors and developed an elite team with multi-disciplinary expertise in chemistry, biology, pharmacology, artificial intelligence, and data structures to ease the pains of patients all over the world.

FDA Approval 52

FDA Approval FDA Drugs Science 52

The Pharma Data

DECEMBER 17, 2020

With years of pharmaceutical expertise to her credit, Dr. Johnson first garnered inspiration for her professional future during her formative years. After relocating to Montgomery, Alabama, she retained this title and its responsibilities at Jackson Hospital from 2008 to 2015. About Marquis Who’s Who® Since 1899, when A.

Pharmacy 52

Pharmacy Doctors Hospitals DNA 52

The Pharma Data

JANUARY 14, 2021

Dr. Dickstein enjoyed 30 years in the pharmaceutical field before retiring in 1998 as the vice president of clinical research for Transcend Therapeutics, Inc. Dickstein remains a pharmaceutical consultant in his hometown of Cohasset, Massachusetts, since 1999.

Laboratories 52

Laboratories Clinical Research Hospitals Pharmaceuticals 52

The Pharma Data

JANUARY 21, 2021

Caggiano joins Evolve Biologics after most recently serving as CEO of Dendreon Pharmaceuticals LLC. Among his earlier leadership roles in the biotech, pharmaceutical and medical device industries, Caggiano directed the divestiture of Allergan’s LAP-BAND to Apollo Endosurgery in 2013. Abbott Laboratories and TAP Pharmaceuticals.

Laboratories 52

Laboratories Pharmaceuticals Engineering Clinical Development 52

Drug Target Review

APRIL 9, 2024

These compounds were later licensed to the pharmaceutical industry for clinical development. Since 2015 Oscar is also the Vice Director of CNIO as well as Director of its Molecular Oncology Programme, and professor at the Karolinska Institute in Sweden.

RNA 65

RNA Cell Biology Clinical Development DNA 65

Molecular Design

OCTOBER 20, 2024

Whether or not ML models ultimately prove to be fit for this purpose it is worth pointing out that many visionaries and thought leaders who tout computation as a panacea to humanity’s ills fail to recognize the complexity of biology (take a look at In The Pipeline posts from 2007 | 2015 | 2024 ).

Metabolic Stability 84

Metabolic Stability Drugs Pharmaceuticals 84

The Pharma Data

APRIL 3, 2021

Johnson & Johnson (the Company) has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson.

Clinical Trials 52

Clinical Trials Vaccine Trials Immune Response 52

The Pharma Data

NOVEMBER 22, 2020

Back in September, Vertex Pharmaceuticals and CRISPR Therapeutics – the company behind the CRISPR Cas-9 platform – announced that the European Medicines Agency (EMA) had granted Priority Medicines (PRIME) designation to CTX001, an investigational ex vivo CRISPR Cas-9 gene-edited therapy for the treatment of severe sickle cell disease.

DNA 52

DNA Medical Schools Treatment RNA 52

The Pharma Data

JANUARY 12, 2021

Akin to the NASA Deep Space Network, SYNERGY-AI OCTCC is a real time data and communication network between patients, sites, and pharmaceutical companies, with the Massive Bio AI-enabled engine orchestrating these stakeholders for successful operations. NEW YORK–( BUSINESS WIRE )– Massive Bio, Inc. , 75N91020C00016.

Clinical Trials 52

Clinical Trials Trials Clinical Research Pharmaceutical Companies 52

NIH Director's Blog: Drug Development

JULY 20, 2017

According to preliminary data from one Phase 1 and two Phase 2 clinical trials reported by Vertex Pharmaceuticals Inc., The next major milestone on the therapeutic pathway was the FDA’s approval in 2015 of Orkambi, a drug that combines ivacaftor with lumacaftor, the first “corrector”.

Clinical Trials 52

Clinical Trials Small Molecule Therapies Disease 52

The Pharma Data

JUNE 19, 2023

A promising new frontier in cancer treatment The study, a collaboration with pharmaceutical company Pfizer Inc., Since 2015, the U.S. centers around a class of new drugs called CDK inhibitors. Each of the enzymes has its own function and place in the process, and scientists believe that 4 and 6 kick-start the cycle.

Drugs 40

Drugs Clinical Trials Pharmaceutical Companies Clinical Development 40

The Pharma Data

MARCH 30, 2021

Additionally, as RMS progresses, it can substantially increase overall healthcare costs as a result of increased disability,” said Haseeb Ahmad, Global Head of Value & Access, Novartis Pharmaceuticals. Novartis obtained rights for ofatumumab from GlaxoSmithKline in all indications, including RMS, in December 2015 8.

Therapies 52

Therapies Treatment Disease Licensing 52

Vial

FEBRUARY 29, 2024

Contract research organizations (CROs) are an integral partner of the drug development process, as they play a pivotal role supporting clinical trial conduct for pharmaceutical, biotechnology, and medical device sponsor companies. Every year, thousands of clinical trials take place, and a large percentage of these are overseen by CROs.

Clinical Trials 52

Clinical Trials Trials Clinical Research Drug Development 52

The Pharma Data

DECEMBER 13, 2020

Prior to that, he held various oncology research and development positions at Merrimack Pharmaceuticals and Archemix. Founded in 2015, EdiGene is headquartered in Beijing, with subsidiaries in Guangzhou, China and Cambridge, Massachusetts, USA. He received his B.S. degree from Henan Normal University, M.S.

Medical Schools 40

Medical Schools Clinical Development Therapies RNA 40

The Pharma Data

APRIL 4, 2023

1 In 2015, the EMA and US FDA approved Humira ® HCF, which contains adalimumab at a concentration of 100 mg/mL. About Sandoz Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. The adalimumab reference medicine (Humira ® *) was first approved with an adalimumab concentration of 50 mg/mL.

Biosimilars 40

Biosimilars Pharmacokinetics FDA Approval Packaging 40

The Pharma Data

OCTOBER 6, 2021

licensed the compound series in 2015, and is continuing to advance the compound into clinical development. Early-stage research suggests potential to prevent and treat all dengue serotypes With no treatments available, dengue infects up to 400 million people each year and the pace of outbreaks is increasing. [1] Janssen Pharmaceutica, N.V.

Virus 52

Virus Clinical Development Science Disease 52

Advarra

JULY 19, 2022

The sponsor is the pharmaceutical company conducting the trial. A: Working in a pharmaceutical company is the best way to learn this. Additional information about this stay can be found in the Notice of Stay published in the Federal Register, October 30, 2015 (80 FR 66907). A: This does not usually happen. of this guidance.

Packaging 52

Packaging FDA Trials Regulations 52

Molecule Blog

AUGUST 13, 2021

Announcing the first biopharma IP-NFT Transaction Funding the first longevity research project by utilizing intellectual property NFTs in the pharmaceutical space Summary The vote has passed, the decision is made: The Scheibye-Knudsen Lab will be the first research organisation to fund their longevity research via an IPNFT.

FDA Approval 52

FDA Approval DNA Small Molecule FDA 52

The Pharma Data

SEPTEMBER 15, 2020

“When Amgen first partnered with us in 2015, MBC BioLabs was a single site in San Francisco hosting 40 companies. We have partnerships with leading pharmaceutical and life-science companies as well as a built-in venture capital firm, Mission BioCapital.

Targeted Protein Degradation 52

Targeted Protein Degradation Molecular Biology Small Molecule Science 52

Agency IQ

JULY 22, 2024

EPA’s regulatory agenda for Spring 2024 Agenda Stage of Rulemaking Title Estimated Publication Former Estimated Date First on Agenda Proposed Rule Stage Removal of Affirmative Defense Provisions from Specified CAA Section 111 and 112 Regulations July 2024 Spring 2024 Final Rule Stage Standards of Performance for New, Reconstructed, and Modified Sources (..)

Regulations 40

Regulations Production Engineering International 40

The Pharma Data

OCTOBER 25, 2020

As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. 2015; Chevallier et al. You are urged to carefully consider all such factors. 1 Gorman et al. . 1 Gorman et al. Annals of Neurology.2015;

Clinical Trials 52

Clinical Trials Trials Small Molecule Regulations 52

Molecular Design

MAY 11, 2019

While the Ro5 article highlighted molecular size and lipophilicity as pharmaceutical risk factors, the rule itself is actually of limited utility as a drug design tool. back in 2015 and you may find this review of that seminal contribution to the drug design literature to be informative.

Metabolic Stability 52

Metabolic Stability Pharmacokinetics Pharmaceuticals Drugs 52

Drug Target Review

OCTOBER 8, 2024

2015 Nov 27 [cited 2024 Sep 27];2. Frontiers in Medicine [Internet].

Pharmacokinetics 52

Pharmacokinetics Engineering Treatment Science 52

Dark Matter Blog

JANUARY 16, 2023

The pharmaceutical industry has had an amazing run at making small molecule medicines for the 15% of protein targets that are seen as “druggable.” This is why Arrakis set out in 2015 on an expedition to figure out how to develop small molecules that can target RNA.

Small Molecule 52

Small Molecule RNA Drugs Disease 52

The Pharma Data

APRIL 6, 2021

In treating patients with PAH, routine comprehensive risk assessment is strongly recommended by the 2015 European Society of Cardiology and the European Respiratory Society (ESC/ERS) Guidelines, as there is no single variable that can provide sufficient diagnostic and prognostic information. IMPORTANT SAFETY INFORMATION. INDICATION.

Treatment 52

Treatment Disease Hospitals Trials 52

The Pharma Data

MARCH 2, 2021

Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the first single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, for individuals 18 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S.

Vaccine 52

Vaccine Clinical Trials FDA Licensing 52

The Pharma Data

MARCH 2, 2021

Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend Emergency Use Authorization (EUA) for the Company’s single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.

Vaccine 40

Vaccine FDA Clinical Trials Trials 40

The Pharma Data

APRIL 20, 2023

“These longer-term data continue to reinforce the favorable safety profile of Kesimpta, as well as its ability to slow disease progression, supporting its earlier use in people with relapsing multiple sclerosis,” said Victor Bultó, President, Innovative Medicines US, Novartis Pharmaceuticals Corporation. Source link: [link]

Treatment 40

Treatment Trials Disease Licensing 40